Inclusive
7078
Renascience
4889
Chordia Therapeutics
190A
Kufu Company Holdings
4376
Cube
7112
(Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | (Q2)Aug 31, 2023 | (Q1)May 31, 2023 | (FY)Feb 28, 2023 | (Q4)Feb 28, 2023 | (Q3)Nov 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -45.45%1.56B | -86.94%-830M | 611.62%3.83B | -29.58%3.55B | 69.15%-2.13B | 257.23%2.87B | -233.33%-444M | 85.13%-749M | 506.62%5.03B | -139.38%-6.92B |
Net profit before non-cash adjustment | 18.99%-128M | 7.27%679M | 621.60%845M | -21.06%-523M | 36.75%893M | 59.28%-158M | 12,560.00%633M | 91.50%-162M | 58.74%-432M | 265.74%653M |
Total adjustment of non-cash items | 165.00%53M | 172.97%81M | -60.99%261M | 2.91%283M | 25.45%69M | -92.51%20M | -254.17%-111M | 497.32%669M | 263.69%275M | -64.29%55M |
-Depreciation and amortization | 1.45%70M | 0.00%67M | -3.75%282M | -2.60%75M | -2.74%71M | -4.17%69M | -5.63%67M | 5.78%293M | 10.00%77M | 1.39%73M |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | -35.34%183M | ---- | ---- | ---- | ---- | 112.78%283M | ---- | ---- |
-Disposal profit | --0 | 99.46%-1M | 41.05%-214M | 124.39%10M | 71.23%-21M | 93.63%-17M | -1,133.33%-186M | -25.61%-363M | 86.60%-41M | -7,400.00%-73M |
-Pension and employee benefit expenses | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --491M | --0 | --0 |
-Other non-cash items | 46.88%-17M | 87.50%15M | 128.57%10M | 134.09%15M | -65.45%19M | 31.91%-32M | 700.00%8M | -288.89%-35M | -257.14%-44M | 558.33%55M |
Changes in working capital | -45.48%1.64B | -64.53%-1.59B | 317.75%2.72B | -27.20%3.79B | 59.44%-3.1B | 224.43%3B | -477.73%-967M | 61.39%-1.25B | 28,983.33%5.2B | -187.75%-7.63B |
-Change in receivables | -36.56%989M | -107.78%-76M | 153.31%790M | -47.84%2.16B | 18.46%-3.91B | 956.59%1.56B | 249.62%977M | -41.28%-1.48B | 184.63%4.15B | -64.18%-4.79B |
-Change in inventory | 212.37%645M | -75.52%201M | 135.71%595M | -33.08%261M | 131.52%87M | 68.60%-574M | 1,610.42%821M | -189.24%-1.67B | 822.22%390M | -68.29%-276M |
-Change in payables | -108.38%-143M | 24.47%-1.84B | -50.42%1.18B | 74.88%1.89B | 101.04%23M | -37.93%1.71B | -421.05%-2.44B | 240.97%2.39B | 205.45%1.08B | -945.02%-2.21B |
-Provision for loans, leases and other losses | -27.94%-87M | 38.24%94M | 95.10%-10M | -29.17%-93M | 730.00%83M | -7.94%-68M | 186.08%68M | -628.57%-204M | 52.63%-72M | -90.38%10M |
-Changes in other current assets | 416.13%160M | 23.97%-111M | -515.00%-123M | 153.49%109M | -1,000.00%-117M | -54.41%31M | -1.39%-146M | -66.67%-20M | -83.59%43M | 143.33%13M |
-Changes in other current liabilities | -79.19%72M | 158.30%144M | 207.87%288M | -40.05%-549M | 294.72%738M | 92.22%346M | -176.23%-247M | -324.37%-267M | 22.22%-392M | -166.61%-379M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -43.48%-33M | -34.78%-31M | -27.27%-126M | -15.38%-45M | -12.90%-35M | -35.29%-23M | -91.67%-23M | -175.00%-99M | -254.55%-39M | -210.00%-31M |
Interest received (cash flow from operating activities) | 41.94%44M | 13.33%17M | -6.93%94M | 16.67%28M | 0.00%20M | -22.50%31M | -11.76%15M | 5.21%101M | -11.11%24M | -9.09%20M |
Tax refund paid | -110.00%-7M | -91.76%-163M | 50.43%-58M | 72.09%-12M | 39.22%-31M | 62.79%70M | -28.79%-85M | 38.42%-117M | -7.50%-43M | 26.09%-51M |
Other operating cash inflow (outflow) | 0 | 0 | 94.67%-25M | 85.19%-4M | 99.75%-1M | 102.70%1M | -21M | -46,800.00%-469M | -27M | -405M |
Operating cash flow | -46.77%1.57B | -80.47%-1.01B | 378.84%3.72B | -29.04%3.51B | 70.47%-2.18B | 254.27%2.94B | -305.15%-558M | 74.20%-1.33B | 492.16%4.95B | -150.59%-7.39B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -2,500.00%-24M | -117.55%-33M | -229.15%-669M | -282.74%-879M | -89.01%21M | 103.33%1M | 251.61%188M | 296.21%518M | 393.29%481M | 441.07%191M |
Net intangibles purchase and sale | 12.50%-7M | 94.69%-6M | -50.98%-154M | -450.00%-22M | 87.36%-11M | 11.11%-8M | -5,550.00%-113M | -82.14%-102M | ---4M | ---87M |
Net investment product transactions | --0 | --2M | -132.61%-316M | ---- | ---- | --0 | --0 | 426.63%969M | -102.44%-6M | 191.94%181M |
Repayment of advance payments to other parties and cash income from loans | ---- | ---- | -94.44%1M | ---- | ---- | ---- | ---- | 38.46%18M | --0 | 70.00%17M |
Net changes in other investments | 150.00%3M | 185.71%12M | -115.57%-26M | 175.00%3M | -104.86%-9M | -133.33%-6M | 56.25%-14M | 3,240.00%167M | 87.50%-4M | 1,641.67%185M |
Investing cash flow | -115.38%-28M | -140.98%-25M | -174.14%-1.16B | -359.74%-1.21B | -99.79%1M | -102.66%-13M | -51.97%61M | 1,430.51%1.57B | 9,440.00%467M | 12,075.00%487M |
Financing cash flow | ||||||||||
Net issuance payments of debt | 37.66%-2.4B | -5.88%1.6B | -127.91%-2.45B | 39.58%-2.9B | -54.59%2.6B | -113.89%-3.85B | 950.00%1.7B | -117.45%-1.08B | -308.70%-4.8B | 73.48%5.73B |
Net common stock issuance | ---73M | ---70M | -282.35%-130M | ---78M | ---- | ---- | --0 | 81.72%-34M | --0 | --0 |
Cash dividends paid | --0 | -47.83%-136M | 0.00%-184M | --0 | 0.00%-93M | --1M | -1.10%-92M | 0.54%-184M | --0 | -1.09%-93M |
Net other fund-raising expenses | -9.09%-12M | 7.69%-12M | 30.77%-45M | 42.86%-8M | 13.33%-13M | 42.11%-11M | 23.53%-13M | -8.33%-65M | 17.65%-14M | 0.00%-15M |
Financing cash flow | 35.62%-2.49B | -13.35%1.38B | -106.85%-2.81B | 37.97%-2.99B | -56.52%2.44B | -111.62%-3.86B | 573.29%1.6B | -123.70%-1.36B | -315.01%-4.81B | 77.92%5.62B |
Net cash flow | ||||||||||
Beginning cash position | -21.29%3.5B | -6.27%3.12B | -24.32%3.33B | 37.59%3.82B | -12.64%3.54B | -1.51%4.44B | -24.32%3.33B | 13.59%4.4B | -18.44%2.78B | 27.31%4.05B |
Current changes in cash | -1.83%-946M | -68.12%350M | 77.16%-256M | -214.12%-687M | 120.45%262M | -84.33%-929M | 1,670.97%1.1B | -352.48%-1.12B | -38.07%602M | -698.60%-1.28B |
Effect of exchange rate changes | 3.85%27M | 109.09%23M | -4.00%48M | 84.78%-7M | 125.00%18M | -40.91%26M | -75.00%11M | -39.76%50M | -270.37%-46M | 0.00%8M |
Cash adjustments other than cash changes | ---- | ---- | ---1M | ---3M | ---- | ---- | 0.00%1M | ---- | ---- | ---- |
End cash Position | -27.15%2.58B | -21.29%3.5B | -6.27%3.12B | -6.27%3.12B | 37.59%3.82B | -12.64%3.54B | -1.51%4.44B | -24.32%3.33B | -24.32%3.33B | -18.44%2.78B |
Free cash flow | -47.31%1.54B | -42.51%-1.05B | 252.29%2.6B | -46.41%2.62B | 70.68%-2.21B | 268.06%2.92B | -602.74%-734M | 68.94%-1.7B | 430.36%4.9B | -151.02%-7.54B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |